Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
暂无分享,去创建一个
S E Hufton | P. Coulie | S. Hufton | P. Chames | B. Uchánska‐Ziegler | P Chames | H. Hoogenboom | H R Hoogenboom | P G Coulie | B Uchanska-Ziegler
[1] C. Janeway,et al. A novel MHC class II epitope expressed in thymic medulla but not cortex , 1989, Nature.
[2] S. Kurtzman,et al. Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine. , 1996, Cancer research.
[3] C. Seitz,et al. The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classical HLA class I molecules. , 1998, Molecular immunology.
[4] A. Chang,et al. Clinical implications of the new biology in the development of melanoma vaccines , 1999, Journal of surgical oncology.
[5] R. Steinman,et al. High Levels of a Major Histocompatibility Complex II–Self Peptide Complex on Dendritic Cells from the T Cell Areas of Lymph Nodes , 1997, The Journal of experimental medicine.
[6] J. Zeuthen,et al. Recognition of insulin on MHC-class-II-expressing L929 cells by antibody and T cells. , 1989, Research in immunology.
[7] P. Coulie,et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 , 1999, International journal of cancer.
[8] L. Fugger,et al. Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: novel reagents for basic and clinical investigations and immunotherapy. , 1999, Immunotechnology : an international journal of immunological engineering.
[9] J. Arends,et al. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma. , 1998, Cancer research.
[10] D. Wiley,et al. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Davies,et al. A scanning tunnelling microscopy comparison of passive antibody adsorption and biotinylated antibody linkage to streptavidin on microtiter wells. , 1994, Journal of immunological methods.
[12] R. Arnon,et al. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex , 1991, Nature.
[13] J. Ozols,et al. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Wraith,et al. Searching for MHC‐restricted anti‐viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza‐infected cells , 1987, European journal of immunology.
[15] D. Stuart,et al. Production, crystallization, and preliminary X‐ray analysis of the human MHC class Ib molecule HLA‐E , 1998, Protein science : a publication of the Protein Society.
[16] A. Plückthun,et al. Correctly folded T-cell receptor fragments in the periplasm of Escherichia coli. Influence of folding catalysts. , 1994, Journal of molecular biology.
[17] P. Cresswell,et al. Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.
[18] H R Hoogenboom,et al. Designing and optimizing library selection strategies for generating high-affinity antibodies. , 1997, Trends in biotechnology.
[19] P. A. Peterson,et al. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.
[20] M. Weijtens,et al. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. , 1996, Journal of immunology.
[21] G. Cornelis,et al. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. , 1999, Journal of immunology.
[22] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[23] P. S. Andersen,et al. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Butler,et al. The physical and functional behavior of capture antibodies adsorbed on polystyrene. , 1992, Journal of immunological methods.
[25] J. Yewdell,et al. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Lidholm,et al. BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip. , 1997, Analytical biochemistry.
[27] E. Unanue,et al. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. , 1997, Immunity.
[28] E. Meinl,et al. Refolding of human class II major histocompatibility complex molecules isolated from Escherichia coli. Assembly of peptide-free heterodimers and increased refolding-yield in the presence of antigenic peptide. , 1994, The Journal of biological chemistry.
[29] J. Kirkwood,et al. New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines , 1996, Melanoma research.
[30] P. Ebbesen,et al. Expression of HLA class I molecules in human first trimester and term placenta trophoblast , 1996, Cell and Tissue Research.
[31] A. Rudensky,et al. Major Histocompatibility Complex Class II Compartments in Human and Mouse B Lymphoblasts Represent Conventional Endocytic Compartments , 1997, The Journal of cell biology.
[32] R. Coleman,et al. The potential of melanoma antigen expression in cancer therapy. , 1999, Cancer treatment reviews.
[33] Hennie R. Hoogenboom,et al. A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies* , 1999, The Journal of Biological Chemistry.
[34] B. Groner,et al. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] R. Germain,et al. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Hicklin,et al. beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. , 1998, The Journal of clinical investigation.
[37] P. Romero,et al. HLA Photoaffinity Labeling Reveals Overlapping Binding of Homologous Melanoma-associated Gene Peptides by HLA-A1, HLA-A29, and HLA-B44 (*) , 1996, The Journal of Biological Chemistry.
[38] L. Terracciano,et al. © 1999 Cancer Research Campaign Article no. bjoc.1999.0810 Expression of MAGE-1 and-3 genes and gene products in human hepatocellular carcinoma , 2022 .
[39] A. Rudensky,et al. A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex‐specific monoclonal antibody , 1996, European journal of immunology.
[40] R. Tampé,et al. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] A. McMichael,et al. Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells , 1999, The Journal of experimental medicine.
[42] B. Nag,et al. Refolding and Reconstitution of Functionally Active Complexes of Human Leukocyte Antigen DR2 and Myelin Basic Protein Peptide from Recombinant and Polypeptide Chains (*) , 1995, The Journal of Biological Chemistry.
[43] G. Fleuren,et al. T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition? , 1994, Immunology today.
[44] K. Parker,et al. Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides. , 1992, The Journal of biological chemistry.
[45] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[46] I. Pastan,et al. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[47] T. Clackson,et al. Making antibody fragments using phage display libraries , 1991, Nature.
[48] J. Yewdell,et al. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. , 1997, Immunity.
[49] R. Arnon,et al. Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein. , 1997, Journal of immunology.
[50] A. Rudensky,et al. Monoclonal antibody detection of a major self peptide. MHC class II complex. , 1992, Journal of immunology.
[51] Catia,et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E , 1992, The Journal of experimental medicine.
[52] R. Germain,et al. Antigen-unspecific B Cells and Lymphoid Dendritic Cells Both Show Extensive Surface Expression of Processed Antigen–Major Histocompatibility Complex Class II Complexes after Soluble Protein Exposure In Vivo or In Vitro , 1997, The Journal of experimental medicine.
[53] H R Hoogenboom,et al. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.